Manchester Capital Management’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-19,984
| Closed | -$118K | – | 541 |
|
|
2019
Q3 | $118K | Hold |
19,984
| – | – | 0.01% | 279 |
|
|
2019
Q2 | $240K | Hold |
19,984
| – | – | 0.03% | 217 |
|
|
2019
Q1 | $241K | Hold |
19,984
| – | – | 0.03% | 213 |
|
|
2018
Q4 | $336K | Hold |
19,984
| – | – | 0.05% | 167 |
|
|
2018
Q3 | $297K | Hold |
19,984
| – | – | 0.04% | 186 |
|
|
2018
Q2 | $336K | Hold |
19,984
| – | – | 0.05% | 169 |
|
|
2018
Q1 | $458K | Hold |
19,984
| – | – | 0.07% | 138 |
|
|
2017
Q4 | $517K | Hold |
19,984
| – | – | 0.08% | 128 |
|
|
2017
Q3 | $295K | Hold |
19,984
| – | – | 0.05% | 151 |
|
|
2017
Q2 | $279K | Hold |
19,984
| – | – | 0.04% | 161 |
|
|
2017
Q1 | $341K | Hold |
19,984
| – | – | 0.05% | 142 |
|
|
2016
Q4 | $206K | Buy |
19,984
+5,000
| +33% | +$51.5K | 0.03% | 175 |
|
|
2016
Q3 | $151K | Hold |
14,984
| – | – | 0.02% | 228 |
|
|
2016
Q2 | $168K | Hold |
14,984
| – | – | 0.02% | 215 |
|
|
2016
Q1 | $205K | Hold |
14,984
| – | – | 0.03% | 194 |
|
|
2015
Q4 | $284K | Hold |
14,984
| – | – | 0.04% | 178 |
|
|
2015
Q3 | $281K | Buy |
+14,984
| New | +$281K | 0.05% | 158 |
|